Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Perampanel

An antiepileptic approved in 2012 in Europe and the United States for focal seizures and, later, also for primary generalised tonic-clonic seizures, as add-on treatment. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It was the first antiepileptic in the class of selective non-competitive antagonists of AMPA receptors, which respond to glutamate, the brain's main excitatory neurotransmitter.

PerampanelGo to the active ingredient →
PerampanelActive ingredientPerampanelCat. No. P-P058-001CAS 380917-97-5
Perampanel-d5Isotopically labelledPerampanel-d5Cat. No. P-P058-002CAS 2012598-62-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.